EQS-News
Zur Rose Group AG publishes invitation to the Annual General Meeting on 29 April 2021 - Seite 3
Investors and analyst contact
Christoph Herrmann, Head of Investor Relations
Email: ir@zurrose.com, phone: +41 58 810 11 49
Media contact
Lisa Lüthi, Head of Group Communications
Email: media@zurrose.com, phone: +41 52 724 08 14
Agenda
The Zur Rose Group is planning to hold a Capital Markets Day in the second quarter of 2021. The precise date and agenda will be announced at a later date.
20 April 2021 First Quarter Trading Update
29 April 2021 Annual General Meeting
18 August 2021 Half-Year Results
21 October 2021 Q3 Trading Update
Zur Rose Group
The Swiss Zur Rose Group is Europe's largest e-commerce pharmacy and one of the leading medical wholesalers in Switzerland. It also operates the leading marketplace in southern Europe for consumer health, beauty and personal care products commonly sold in pharmacies. The company is internationally present with strong brands, including Germany's best-known pharmacy brand, DocMorris, and employs more than 2,200 people at sites in Switzerland, Germany, the Netherlands, Spain and France. Now serving 10.5 million active customers in core European markets, Zur Rose generated revenue of CHF 1,752 million (including Medpex and Apotal) in 2020.
With its business model, the Zur Rose Group offers high-quality, safe and cost-effective pharmaceutical care. It also excels in continuous development of digital healthcare services and as a platform technology provider. In addition, Zur Rose is actively driving forward its positioning as a comprehensive healthcare service provider, with focus on building up its European healthcare ecosystem networking qualified providers of products, services and digital solutions. Zur Rose's contribution will be to bring these offerings to customers and patients, pursuing its vision of creating a world where people can manage their own health in one click.
Lesen Sie auch
The shares of Zur Rose Group AG are listed on the SIX Swiss Exchange (securities number 4261528, ISIN CH0042615283, ticker ROSE). For further information, please visit zurrosegroup.com.
End of Media Release
Language: | English |
Company: | Zur Rose Group AG |
Walzmühlestrasse 60 | |
8500 Frauenfeld | |
Switzerland | |
Phone: | +41 52 724 08 14 |
Internet: | www.zurrosegroup.com |
ISIN: | CH0042615283 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 1181355 |